Mazyar Shadman: Venetoclax – based therapy after cBTKi in CLL led by Nilanjan Ghosh
Mazyar Shadman, Associate Professor of Medical Oncology at Fred Hutch Cancer Centre, shared on X
“Just out at American Journal of Hematology.
Venetoclax – based therapy after cBTKi in CLL led by Nilanjan Ghosh.
Kudos to the CORE team and Beenish Manzoor for building the CORE registry.
Looking forward to having more studies using CORE.”
Authors: Nilanjan Ghosh, Toby A. Eyre, Jennifer R. Brown, Nicole Lamanna, Beenish S. Manzoor, Catherine C. Coombs, Hande H. Tuncer, Chaitra Ujjani, Lori A. Leslie, Lindsey E. Roeker, Matthew S. Davids, Joanna M. Rhodes, Alan P. Skarbnik, Wendy Sinai, Isabelle Fleury, Brian T. Hill, Nicolas Martinez-Calle, Paul M. Barr, Dureshahwar Jawaid, Nnadozie Emechebe, Laurie Pearson, Frederick Lansigan, Yun Choi, Christopher E. Jensen, Bita Fakhri, Deborah M. Stephens, Steven E. Marx, Stephen J. Schuster, Michael Coyle, Irina Pivneva, Talissa Watson, Annie Guerin, Mazyar Shadman
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023